Dermatitis
Dermatitis is an umbrella term for skin inflammation conditions like eczema, contact dermatitis, and seborrheic dermatitis, characterized by symptoms such as dry skin, redness, itchiness, and sometimes small blisters or thickened skin. The affected skin area can range from small patches to the entire body.
Health Outcomes
- Antibacterial Activity Against Bacillus subtilis
- Cosmetic Material Identification
- Enhanced Epithelial Cell Migration
- Enhanced Immune Response to Gram-Positive Bacteria
- Enhanced Safety in Topical Application
- Improved Epidermal Moisturization
- Improved Epithelial Integrity
- Improved Epithelial Protection
- Improved Facial Skin Hydration
- Improved Skin Barrier Function
- Improved Skin Condition Score
- Improved Skin Disease Severity
- Improved Skin Elasticity
- Improved Skin Health
- Improved Skin Hydration
- Improved Skin Moisture Retention
- Improved Skin Responses
- Improved Skin Symptoms
- Improved Tissue Pathology
- Increased Antigen-Specific IgG1 Levels
- Maintained Barrier Function
- Maintained Remission of Skin Symptoms
- Maintained Soft-Tissue Health
- No Significant Change in Inflammatory Responses
- Potential Skin Effect
- Prevention or Treatment of Allergic Skin Disorders
- Reduced 12-Month Prevalence of Eczema at Age 11 Years
- Reduced Allergic Contact Dermatitis
- Reduced Atopic Dermatitis Severity
- Reduced Ceramide Production
- Reduced Dermal Irritation
- Reduced Dermatitis Incidence
- Reduced Eczema Incidence
- Reduced Erythema Intensity
- Reduced Infant Atopic Eczema and Allergic Disease
- Reduced Offspring Eczema Risk
- Reduced Pruritus
- Reduced Radiation-Induced Dermatitis Severity
- Reduced S. aureus Adhesion
- Reduced SCORAD Index
- Reduced Scratching Behavior
- Reduced Scratching Frequency
- Reduced Skin Dryness Symptoms
- Reduced Skin Inflammation
- Reduced Skin Redness
- Reduced Toxicity from Sodium Dodecyl Sulfate
- Restored Barrier Function
- Unchanged Inflammatory Response